Adventrx Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Adventrx Pharmaceuticals Inc
TickerSVRA
CIK #0001160308
CUSIP805111101
SectorLife Sciences - Pharmaceutical Preparations
Address12390 El Camino Real Suite 150, San Diego, CA 92130
Source [EDGAR]
CIK Filing 2011 - 2025
[0001160308] 10-K
[0001160308] 10-Q
[0001160308] 3
[0001160308] 4
[0001160308] 8-K
[0001160308] D
[0001160308] SC 13D
[0001160308] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Venrock Healthcare Capital Partners III LP Savara Inc [2025-07-08] 0.0
Vestal Point Capital LP Savara Inc [2025-02-14] 0.0
Frazier Life Sciences Public Fund LP Savara Inc [2024-11-27] 8194.0
Wellington Management Group LLP Savara Inc [2024-11-08] 5.24
BlackRock Inc Savara Inc [2024-11-08] 5.7
BlackRock Inc Savara Inc [2024-10-24] 5.7
Prudential Financial Inc Savara Inc [2024-02-13] 7.23
Jennison Associates LLC Savara Inc [2024-02-08] 6.5
BlackRock Inc Savara Inc [2024-01-31] 5.4
TCG Crossover GP I LLC Savara Inc [2023-07-25] 7.4
Adage Capital Partners GP LLC Savara Inc [2021-03-25] 6.53
Growth Equity Opportunities 17 LLC Savara Inc [2021-03-25] 24.2
Caxton Corp Savara Inc [2021-03-19] 6.2
BlackRock Inc Savara Inc [2021-02-02] 5.6
EcoR1 Capital LLC Savara Inc [2020-01-06] 8.3
Bain Capital Life Sciences Fund II LP Savara Inc [2019-12-30] 0.99
Altium Capital Management LP Savara Inc [2019-07-22] 6.27
BlackRock Inc Savara Inc [2019-02-08] 6.3
Consonance Capital Management LP Savara Inc [2018-02-14] 8.51
Zambon Spa Savara Inc [2017-06-29] 19.5
Farallon Capital Management LLC Savara Inc [2017-06-12] 2.2
Sabby Management LLC Mast Therapeutics Inc [2016-02-12] 6.69
Sabby Management LLC Mast Therapeutics Inc [2014-11-07] 3.67
Franklin Resources Inc Mast Therapeutics Inc [2013-07-10] 10.7
Sabby Management LLC Mast Therapeutics Inc [2013-06-25] 0.99
Great Point Partners LLC Mast Therapeutics Inc [2013-06-24] 8.77
Flynn James E Mast Therapeutics Inc [2013-06-21] 6.09
FMR LLC Adventrx Pharmaceuticals Inc [2012-02-14] 0.0
Marxe Austin W & Greenhouse David M Adventrx Pharmaceuticals Inc [2012-02-13] 7.91
Form 3/4/5 Filer 2011 - 2025
Savara Inc
Hawkins Richard J
McCracken Joseph S
Ramsay David A
McCabe Kathleen R.
Lutz Robert Matthew
Parker Braden C.
Erickson Anne
van Es-Johansson An
Elam Nevan C
Pauls Matthew
Pratt Raymond Dennis
Lowrance David L
Sun Ricky
Yang Rick
Chang Carmen
Florence Anthony A. Jr.
Makhzoumi Mohamad
Mathers Edward T
Sandell Scott D
Walker Paul Edward
New Enterprise Associates 17, L.P.
NEA Partners 17, L.P.
NEA 17 GP LLC
Growth Equity Opportunities 17, LLC
Baskett Forest
Behbahani Ali
Chowdhury Badrul A.
Sonsini Peter W.
Landsman Liza
Makower Joshua
Neville Robert N
Jouhikainen Jaakko Taneli
Pikover YURI
Zambon SpA
Zambon Co SpA
Serenova a/s
Culley Brian M
Parsley Edwin L.
Dittrich Howard
Roberts Brandi
Greenleaf Peter
Hood Shana
Emanuele Robert Martin
Gorgas Gregory D.
Lief Jack
Shuster Lewis
Keran Patrick L
Vetticaden Santosh
Love Ted W
Form 13F Holdings
Firm Period DFND Voting Shares
NEA Management Company LLC [2025-06-30] DFND 24,471,264 24,471,264
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 17,600,621 17,600,621
TCG Crossover Management LLC [2025-06-30] SOLE 12,362,205 12,362,205
Frazier Life Sciences Management LP [2025-06-30] SOLE 11,462,301 11,462,301
Vestal Point Capital LP [2025-06-30] SOLE 11,015,000 11,015,000
BlackRock, Inc. [2025-06-30] SOLE 9,571,532 9,775,573
VR Adviser LLC [2025-06-30] SOLE 8,884,263 8,884,263
Nantahala Capital Management LLC [2025-06-30] SOLE 8,325,375 8,325,375
Vanguard Group Inc [2025-06-30] SOLE 0 8,221,994
Deerfield Management Company LP [2025-06-30] DFND 7,964,000 7,964,000
Farallon Capital Management LLC [2025-06-30] OTR 6,835,000 6,835,000
Adar1 Capital Management LLC [2025-06-30] SOLE 3,600,670 3,600,670
Emerald Advisers LLC [2025-06-30] SOLE 2,615,409 3,534,368
Wellington Management Group LLP [2025-06-30] DFND 0 3,350,272
Geode Capital Management LLC [2025-06-30] DFND 2,970,183 2,970,183
Rosalind Advisors, Inc. [2025-06-30] SOLE 2,654,944 2,654,944
Sofinnova Investments Inc [2025-06-30] SOLE 2,457,352 2,457,352
State Street Corp [2025-06-30] DFND 2,278,445 2,456,941
Emerald Mutual Fund Advisers Trust [2025-06-30] SOLE 2,186,404 2,186,404
Sphera Funds Management Ltd [2025-06-30] DFND 1,310,233 1,310,233
Superstring Capital Management LP [2025-06-30] SOLE 1,115,379 1,115,379
Northern Trust Corp [2025-06-30] DFND 1,051,841 1,051,841
AXA Sa [2025-06-30] DFND 1,050,126 1,050,126
Charles Schwab Investment Management Inc [2025-06-30] SOLE 995,511 995,511
Deutsche Bank AG [2025-06-30] DFND 622,979 831,045
Voya Investment Management LLC [2025-06-30] DFND 0 797,118
SIO Capital Management LLC [2025-06-30] SOLE 726,851 726,851
GSA Capital Partners LLP [2025-06-30] SOLE 708,463 708,463
Dimensional Fund Advisors LP [2025-06-30] SOLE 504,383 601,037
Goldman Sachs Group Inc [2025-06-30] DFND 530,078 530,078
Prev | Page 7 | Next
Terms | Privacy | Guide
tony@aum13f.com